Astellas Pharma announced changes to its top management structure, effective October 1, 2025.
Nick Eshkenazi, current Chief Digital & Transformation Officer (CDTO), will leave Astellas on September 30, 2025. Consequently, effective October 1, 2025, the position of CDTO will be removed from Top Management, with both Digital and Transformation functions being integrated into the Strategy function, led by Adam Pearson, the Chief Strategy Officer (CStO).
- Top Management (Effective October 1, 2025)
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from American Pharmaceutical Review – all delivered right to your inbox!
Sign up now!